IMMUNO - ONCOLOGY FRONTIERS

 

web

Welcome to Immuno-Oncology Frontiers

The perfect combination of strategic vision and emerging science

#

2017 Speakers


 

It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer.

Lance Leopold MD, Vice President, Head of Oncology Development, Incyte Corporation

Show the sponsors

Gold

logo                    #

Silver

logo

Bronze

View all Sponsors

Associate


 

Advisory Board